BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37351956)

  • 21. A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma.
    Zhang H; Ye Q; Chen Z; Zhao C; Wu Q; Ding Y; Shao Q; Zhao Y
    Dis Markers; 2022; 2022():8928282. PubMed ID: 36438902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Su H; Sun T; Wang H; Shi G; Zhang H; Sun F; Ye D
    Oncotarget; 2017 Jan; 8(4):5789-5799. PubMed ID: 27494890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Ning L; Li Z; Wei D; Chen H; Yang C
    Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing a prognostic model based on five starvation-related long non-coding RNAs for clear cell renal cell carcinoma.
    Yu Z; Chen G; Feng Z; Li Y; Yu H; Shi W; Gou X; Zhang C; Peng X
    Aging (Albany NY); 2023 Jun; 15(14):6736-6748. PubMed ID: 37341994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.
    Wang Y; Li Z; Li W; Zhou L; Jiang Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17276. PubMed ID: 31577719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.
    Sun C; Zhou Z; Shi H; Li F; Zhang G
    Dis Markers; 2019; 2019():2814058. PubMed ID: 31871500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
    Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
    Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma.
    Cheng G; Yu Y; Wang L; Pan Q
    Aging (Albany NY); 2020 Apr; 12(8):7448-7464. PubMed ID: 32315986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
    Yang K; Lu XF; Luo PC; Zhang J
    Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
    [No Abstract]   [Full Text] [Related]  

  • 36. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
    Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
    Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
    Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
    J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.